All News

Reevaluating Treatment for Penile Cancer to Avoid Surgery

September 16th 2021, 3:00pm


A first-of-its-kind trial underway in patients with penile cancer may lead to a more effective therapy sequence, potentially avoiding unnecessary surgery.

Fear of Dying From Cancer Shouldn't Stop You From Living

September 16th 2021, 1:00pm


Through the emotions and anxiety of cancer, she realized she was not living her life to the fullest, and that it isn't over yet.

FDA Approves Exkivity as First Oral Therapy for Lung Cancer Subset

September 15th 2021, 9:29pm


The FDA’s approval of Exkivity marks the first approved oral therapy for this subgroup of patients with non-small cell lung cancer.

Tecartus for MCL: Expert Reflects After a Year Since FDA Approval

September 15th 2021, 9:00pm


Tecartus was the first CAR-T cell therapy to be approved for the treatment of recurrent mantle cell lymphoma. Now, more than a year after its approval, a doctor discusses his experience prescribing the drug.

Immunotherapy Offers Certain Patients With Small Cell Lung Cancer A ‘Ray of Hope’, Expert Says

September 15th 2021, 7:00pm


Although immunotherapy has provided patients with small cell lung cancer with a “light at the end of the tunnel,” an expert from City of Hope argues more research is needed.

Cancer Survivors Are Tired of Being Afraid

September 15th 2021, 5:00pm


A cancer survivor describes how survivors can help face their fears by connecting with each other.

The Importance of Active Surveillance in Low-Risk Prostate Cancer

September 15th 2021, 3:00pm


Monitoring, rather than immediately treating, patients with low-risk prostate cancer may be a better approach, says an expert from UCSF Helen Diller Family Comprehensive Cancer Center.

FDA Approves Brukinsa for Marginal Zone Lymphoma Treatment

September 15th 2021, 1:18pm


Patients with relapsed/refractory, pretreated marginal zone lymphoma are now eligible for treatment with Brukinsa.

Managing Essential Thrombocythemia

September 15th 2021, 1:00pm


An expert explains the treatment options and personal life impacts of an essential thrombocythemia diagnosis.

New Drug Shows Promise for Advanced Pancreatic Cancer

September 14th 2021, 9:00pm


GC4419 plus radiation improved progression-free survival and time to distant metastases in patients with unresectable or borderline resectable locally advanced pancreatic cancer.